Skip to main content
IBD: Switching from ADA originator to biosimilar SB5 appears effective and safe
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
IBD: Switching from ADA originator to biosimilar SB5 appears effective and safe
User login
Username
Password
Reset your password
Concept
Lead
score
Inflammatory Bowel Disease
1
0.97
Biologic Therapy
0
0.81
Biosimilars
0
0.81
Remission
0
0.49
Biomarker
0
0.16
Colitis
0
0.16
Grant
0
0.16
Pain
0
0.16
Pain Management
0
0.16
Specialty
Lead
score
Gastroenterology
1
1
Nursing
0
0.91
Pharmacist
0
0.91
Family Medicine/Primary Care
0
0.28
Internal Medicine
0
0.28
Anesthesiology
0
0.16
Edit Tags